Social Security, Medicare clash comes down to what constitutes a ‘cut’
By Mike Lillis for The Hill on 3/6/2023 The coming battles over the nation’s safety-net programs are beginning with an
Read More
Legislative Update
FDA has new leverage over companies looking for a quicker drug approval
(By Sydney Lupkin for NPR) The huge spending bill that became law last December also included fixes to a problem
Read MoreThe radical proposal to let Medicare and Social Security lapse, explained
By Dylan Scott on February 16, 2023 for Vox Sen. Rick Scott wants every government program — even entitlements —
Read More‘We Ain’t Gonna Get It’: Why Bernie Sanders Says His ‘Medicare for All’ Dream Must Wait
By Arthur Allen for Kaiser Health News on February 8, 2023 After railing at the injustices of U.S. health care
Read MoreMedicare announces plan to recoup billions from drug companies
(Leslie Walker and Dan Gorenstein for NPR) Medicare’s historic plan to slow prescription drug spending is taking shape. Thursday federal
Read MoreCOVID test kits, treatments and vaccines won’t be free to many consumers much longer
(By Julie Appleby for NPR) Time is running out for free-to-consumer COVID-19 vaccines, at-home test kits and even some treatments.
Read MoreSenators probe telehealth companies for tracking and monetizing sensitive health data
(By John Wilkerson for STAT) A bipartisan group of senators fiercely criticized several prominent telehealth startups for failing to protect
Read MoreLawmakers reintroduce bill to rename Medicare Advantage plans
(By Andrew Cass for Becker’s Hospital Review) A trio of U.S. representatives has reintroduced a bill that would rename Medicare
Read MoreSenators reintroduce bills to reform PBM industry
(By Jakob Emerson for Becker’s Hospital Review) A bipartisan group of senators are once again pushing for new regulations around
Read MorePresident Biden to end Covid-19 emergencies on May 11
(By Zeke Miller and Amanda Seitz — Associated Press published by STAT on January 30, 2023) WASHINGTON — President Joe
Read More